Company Description
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.
The company sells its products through direct sales organizations, such as capital and clinical sales teams.
It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Country | United States |
| Founded | 1995 |
| IPO Date | Jun 13, 2000 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 13,676 |
| CEO | Dr. Gary S. Guthart Ph.D. |
Contact Details
Address: 1020 Kifer Road Sunnyvale, California 94086 United States | |
| Phone | (408) 523-2100 |
| Website | intuitive.com |
Stock Details
| Ticker Symbol | ISRG |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001035267 |
| CUSIP Number | 46120E602 |
| ISIN Number | US46120E6023 |
| Employer ID | 77-0416458 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gary S. Guthart Ph.D. | Chief Executive Officer and Director |
| David J. Rosa | President |
| Jamie E. Samath | Senior Vice President and Chief Financial Officer |
| Henry L. Charlton | Senior Vice President and Chief Commercial and Marketing Officer |
| Robert DeSantis | Executive Vice President and Chief Strategy and Corporate Operations Officer |
| Fredrik Widman | Vice President, Principal Accounting Officer and Corporate Controller |
| Gary H. Loeb J.D. | Senior Vice President, General Counsel and Chief Compliance Officer |
| Dr. Christopher R. Carlson Ph.D. | Senior Vice President of Research, Corporate Development and Intuitive Ventures |
| Marshall L. Mohr | Executive Vice President of Global Business Services |
| Dr. Myriam J. Curet McAdams F.A.C.S., M.D. | Executive Vice President and Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 15, 2024 | 144 | Filing |
| Mar 14, 2024 | 8-K | Current Report |
| Mar 11, 2024 | 144 | Filing |
| Mar 11, 2024 | 144 | Filing |
| Mar 8, 2024 | 144 | Filing |
| Mar 8, 2024 | 144 | Filing |
| Mar 8, 2024 | ARS | Filing |
| Mar 8, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 8, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 7, 2024 | 144 | Filing |